KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - Deferred ChargesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Repligen (RGEN) EPS (Weighted Average and Diluted) (2016 - 2025)

Repligen (RGEN) has disclosed EPS (Weighted Average and Diluted) for 16 consecutive years, with $0.23 as the latest value for Q4 2025.

  • Quarterly EPS (Weighted Average and Diluted) rose 137.7% to $0.23 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $0.85 through Dec 2025, up 284.78% year-over-year, with the annual reading at $0.86 for FY2025, 286.96% up from the prior year.
  • EPS (Weighted Average and Diluted) for Q4 2025 was $0.23 at Repligen, down from $0.26 in the prior quarter.
  • The five-year high for EPS (Weighted Average and Diluted) was $0.88 in Q2 2022, with the low at -$0.61 in Q4 2024.
  • Average EPS (Weighted Average and Diluted) over 5 years is $0.33, with a median of $0.29 recorded in 2023.
  • The sharpest move saw EPS (Weighted Average and Diluted) crashed 132.94% in 2023, then surged 2700.0% in 2025.
  • Over 5 years, EPS (Weighted Average and Diluted) stood at $0.5 in 2021, then skyrocketed by 70.0% to $0.85 in 2022, then crashed by 132.94% to -$0.28 in 2023, then tumbled by 117.86% to -$0.61 in 2024, then soared by 137.7% to $0.23 in 2025.
  • According to Business Quant data, EPS (Weighted Average and Diluted) over the past three periods came in at $0.23, $0.26, and $0.26 for Q4 2025, Q3 2025, and Q2 2025 respectively.